- Home
- TYRA vs EBF Comparison
TYRA vs EBF Comparison
Compare TYRA & EBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYRA
- EBF
- Stock Information
- Founded
- TYRA 2018
- EBF 1909
- Country
- TYRA United States
- EBF United States
- Employees
- TYRA N/A
- EBF N/A
- Industry
- TYRA Biotechnology: Pharmaceutical Preparations
- EBF Office Equipment/Supplies/Services
- Sector
- TYRA Health Care
- EBF Consumer Discretionary
- Exchange
- TYRA Nasdaq
- EBF Nasdaq
- Market Cap
- TYRA 580.2M
- EBF 488.0M
- IPO Year
- TYRA 2021
- EBF N/A
- Fundamental
- Price
- TYRA $10.37
- EBF $17.55
- Analyst Decision
- TYRA Strong Buy
- EBF
- Analyst Count
- TYRA 7
- EBF 0
- Target Price
- TYRA $30.86
- EBF N/A
- AVG Volume (30 Days)
- TYRA 231.1K
- EBF 164.3K
- Earning Date
- TYRA 08-11-2025
- EBF 09-22-2025
- Dividend Yield
- TYRA N/A
- EBF 5.69%
- EPS Growth
- TYRA N/A
- EBF N/A
- EPS
- TYRA N/A
- EBF 1.51
- Revenue
- TYRA N/A
- EBF $388,707,000.00
- Revenue This Year
- TYRA N/A
- EBF $0.48
- Revenue Next Year
- TYRA N/A
- EBF N/A
- P/E Ratio
- TYRA N/A
- EBF $11.79
- Revenue Growth
- TYRA N/A
- EBF N/A
- 52 Week Low
- TYRA $6.42
- EBF $17.15
- 52 Week High
- TYRA $29.60
- EBF $25.75
- Technical
- Relative Strength Index (RSI)
- TYRA 48.30
- EBF 37.77
- Support Level
- TYRA $10.71
- EBF $17.93
- Resistance Level
- TYRA $11.66
- EBF $18.51
- Average True Range (ATR)
- TYRA 0.63
- EBF 0.34
- MACD
- TYRA -0.01
- EBF -0.02
- Stochastic Oscillator
- TYRA 18.25
- EBF 2.04
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.